Hepatic manifestations of women with polycystic ovary syndrome
MJ Chen, HN Ho�- Best practice & research Clinical obstetrics &�…, 2016 - Elsevier
Highlights•Women with PCOS have a higher prevalence of NAFLD/NASH than the general
population.•Not only obesity and overweight, multiple factors link NAFLD/NASH to
PCOS.•Different androgens have differential effect on the hepatic manifestations in
PCOS.•The common treatments on PCOS affect the liver function.Women with polycystic
ovary syndrome (PCOS) have a higher prevalence of nonalcoholic fatty liver disease
(NAFLD) and nonalcoholic steatohepatitis (NASH) than the general population. The link�…
population.•Not only obesity and overweight, multiple factors link NAFLD/NASH to
PCOS.•Different androgens have differential effect on the hepatic manifestations in
PCOS.•The common treatments on PCOS affect the liver function.Women with polycystic
ovary syndrome (PCOS) have a higher prevalence of nonalcoholic fatty liver disease
(NAFLD) and nonalcoholic steatohepatitis (NASH) than the general population. The link�…